OCGN: Ocugen, Inc.
Performance
OCGN -28.52%
Watchlist
Select an item
Summary
OCGN at a glance
OCGN returned -28.52% over the past year and -37.48% a year over five years. Its worst drop in that year was -71.67%, smaller than 5% of stocks on Redstone, and its Sharpe ratio of -0.05 beats 25% of stocks on Redstone. It pays no dividends.
Current Drawdown
-60.80%
Rolling Volatility
100.46%
Actions
Metrics
Risk Indicators
Alpha-21.27%
Beta1.72x
Sharpe-0.05
Sortino-0.08
Omega0.99
Calmar-0.40
Martin-0.11
Profile
About OCGN
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $330M
- Listed
- Dec 2014
- Employees
- 116
- Headquarters
- Malvern, PA
- Website
- ocugen.com
Comparisons